Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Bronchial Asthma
Interventions
DRUG

montelukast

"Standard case management will be carried out as per guidelines given by British Thoracic Society. All patients will receive montelukast or similar looking placebo tablets. The doses of montelukast will be as follows:~5-12 years: 5 mg chewable tablet of montelukast; \> 12 years: 10 mg chewable tablet of montelukast. Study drug will be administered at time of administration of steroid."

DRUG

Placebo

The patients will receive placebo tablets.

Trial Locations (1)

Unknown

All India Institute of Medical Sciences, New Delhi

All Listed Sponsors
lead

All India Institute of Medical Sciences

OTHER

NCT00565955 - Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children | Biotech Hunter | Biotech Hunter